Ph.D. WEI-WU HE - 09 Jan 2026 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
Ph.D. WEI-WU HE
Reporting Manager
WEI-WU HE, Ph.D.
Symbol
CASI
Shares outstanding
20,761,963 shares
Disclosed Ownership
3,965,535 shares
Ownership
19%
Form type
SCHEDULE 13D/A
Filing time
09 Jan 2026, 06:03:17 UTC
Date of event
09 Jan 2026
Previous filing
18 Dec 2025

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
WEI-WU HE, Ph.D. 19% 3,965,535 2,130,550 1,834,985 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D. 0001542073
HUIYING MEMORIAL FOUNDATION 3.1% 637,644 0 637,644 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./President
EMERGING TECHNOLOGY PARTNERS, LLC 5.3% 1,097,341 0 1,097,341 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./ Managing Member
ETP Global Fund L.P. 3.7% 753,234 0 753,234 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
ETP BIOHEALTH III FUND, L.P. 1.5% 300,000 0 300,000 EMERGING TECHNOLOGY PARTNERS, LLC General Partner
HE Family GRAT 0.5% 100,000 0 100,000 /s/ Wei-Wu He, Ph.D. Wei-Wu He, Ph.D./Trustee